^
Association details:
| Biomarker: | MET expression |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Rozlytrek (entrectinib) (ALK inhibitor, TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor, ROS1 inhibitor, JAK2 inhibitor, TNK2 inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
MET mediates entrectinib resistance in ROS1 gene fusion positiveNSCLC
Published date:
05/15/2020
Excerpt:
CUTO38 is resistant to entrectinib in vitro and displays elevated MET expression…
